The Jimmy Fund started with a boy who loved baseball. The boy dubbed “Jimmy” was a 12-year-old from New England with lymphoma. In 1948, he appeared on a national radio program broadcasted from his hospital room. He was joined by members of his favorite baseball team: the Boston Braves. Jimmy had just one wish: a TV so he could watch his favorite team play. Listeners donated what they could and together ended up raising hundreds of thousands of dollars. With this support, the Jimmy Fund was born—its mission? To support cancer patients at Dana-Farber Cancer Institute, just like Jimmy. Today, 75 years later, the Jimmy Fund community has grown to millions of supporters who are changing how the whole world treats cancer for adults and children.

Jimmy Fund Podcast
Claim This Podcastby Hearst StoryStudio
Podcast Overview
The Jimmy Fund started with a boy who loved baseball. The boy dubbed “Jimmy” was a 12-year-old from New England with lymphoma. In 1948, he appeared on a national radio program broadcasted from his hospital room. He was joined by members of his favorite baseball team: the Boston Braves. Jimmy had just one wish: a TV so he could watch his favorite team play. Listeners donated what they could and together ended up raising hundreds of thousands of dollars. With this support, the Jimmy Fund was born—its mission? To support cancer patients at Dana-Farber Cancer Institute, just like Jimmy. Today, 75 years later, the Jimmy Fund community has grown to millions of supporters who are changing how the whole world treats cancer for adults and children.
Language
🇺🇲
Publishing Since
7/6/2023
11 verified contact emails on file for Jimmy Fund Podcast
Pitch yourself as a guest, propose sponsorships, or reach out directly to the host.
Recent Episodes

July 6, 2023
Jimmy Fund Podcast
We’re here today with Dr. Stephen Sallan, chief of staff emeritus at Dana-Farber, and one of the world’s foremost experts on childhood leukemia. Dr. Sallan is a senior leader within the Dana-Farber and Jimmy Fund community, celebrating 50 years at the Institute in July 2023. His research on leukemia forms the core of clinical programs used by institutions worldwide, and he has been a pioneer in extending leukemia treatments to young adults with that disease.
1 total episodes available
Deep-dive analytics for Jimmy Fund Podcast
Frequently asked questions
Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.
- What is Jimmy Fund Podcast?
- How often does this podcast release new episodes?
This podcast updates daily.
- Where can I listen to this podcast?
This podcast is available on 4 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.
- Does this podcast accept guests?
Yes, this podcast regularly features guests.
Legal Disclaimer
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.
